Table 4.
Example of tabular reporting of patient characteristics [180].
| Patients | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| All | CK-19 mRNA + | CK-19 mRNA - | ||||||||
| Characteristic | Number | % | Number | % | Number | % | P | |||
| Patients enrolled | 444 | 100 | 181 | 40.8 | 263 | 59.2 | ||||
| Age, years | ||||||||||
| Median | 54 | 54 | 55 | |||||||
| Range | 26 to 78 | 26 to 74 | 30 to 78 | 0.752 | ||||||
| Menopausal status | 0.075 | |||||||||
| Premenopausal | 191 | 43 | 87 | 45.5 | 104 | 54.5 | ||||
| Postmenopausal | 253 | 57 | 94 | 37.2 | 159 | 62.8 | ||||
| Tumor size | 0.648 | |||||||||
| T1 | 157 | 35.4 | 61 | 38.9 | 96 | 61.1 | ||||
| T2 | 251 | 56.5 | 103 | 41 | 148 | 59 | ||||
| T3 | 36 | 8.1 | 17 | 47.2 | 19 | 52.8 | ||||
| Histology grade | 0.316 | |||||||||
| I/II | 204 | 46 | 87 | 42.6 | 117 | 57.4 | ||||
| III | 191 | 43 | 72 | 37.7 | 119 | 62.3 | ||||
| Unknown | 49 | 11 | 22 | 27 | ||||||
| Infiltrated axillary lymph nodes | 0.538 | |||||||||
| 0 | 163 | 36.7 | 61 | 37.4 | 102 | 62.6 | ||||
| 1 to 3 | 122 | 27.5 | 53 | 43.5 | 69 | 56.5 | ||||
| ≥4 | 159 | 35.8 | 67 | 42.1 | 92 | 57.9 | ||||
| ER | 0.779 | |||||||||
| Negative | 175 | 39.4 | 71 | 40.6 | 104 | 59.4 | ||||
| Positive | 260 | 58.6 | 109 | 41.9 | 151 | 58.1 | ||||
| Unknown | 9 | 2 | 1 | 8 | ||||||
| PR | 0.126 | |||||||||
| Negative | 234 | 52.7 | 89 | 38 | 145 | 62 | ||||
| Positive | 201 | 45.3 | 91 | 45.3 | 110 | 54.7 | ||||
| Unknown | 9 | 2 | 1 | 8 | ||||||
| HER2 | 0.897 | |||||||||
| 0, 1+ | 290 | 65.3 | 122 | 42.1 | 168 | 57.9 | ||||
| 2+ | 53 | 11.9 | 21 | 39.6 | 32 | 60.4 | ||||
| 3+ by IHC | 88 | 19.8 | 35 | 39.8 | 53 | 60.2 | ||||
| Unknown | 13 | 3 | 3 | 10 | ||||||
| Adjuvant chemotherapy | 0.425 | |||||||||
| CMF | 43 | 9.7 | 14 | 32.6 | 29 | 67.4 | ||||
| FEC | 209 | 47.1 | 84 | 40.2 | 125 | 59.8 | ||||
| EC-T | 192 | 43.2 | 83 | 43.2 | 109 | 56.8 | ||||
| Surgery | 0.478 | |||||||||
| L | 310 | 69.8 | 123 | 39.7 | 187 | 60.3 | ||||
| M | 134 | 30.2 | 58 | 43.3 | 76 | 56.7 | ||||
| Radiotherapy | 0.799 | |||||||||
| No | 81 | 18.2 | 32 | 39.5 | 49 | 60.5 | ||||
| Yes | 363 | 81.8 | 149 | 41 | 214 | 59 | ||||
CK-19: cytokeratin-19; CMF: cyclophosphamide, methotrexate, fluorouracil; EC-T: epirubicin, cyclophosphamide, docetaxel; ER: estrogen receptor; FEC: fluorouracil, epirubicin, cyclophosphamide; IHC: immunohistochemistry; L: lumpectomy; M: mastectomy; PR: progesterone receptor.